KK
VRTX icon

KLP Kapitalforvaltning’s Vertex Pharmaceuticals VRTX Stock Holding History

KLP Kapitalforvaltning’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.6M Buy
95,381
+2,480
+3% +$1.16M 0.17% 111
2025
Q4 		$42.1M Buy
92,901
+260
+0.3% +$112K 0.16% 115
2025
Q3 		$36.3M Sell
92,641
-200
-0.2% -$83.6K 0.14% 133
2025
Q2 		$41.3M Buy
92,841
+5,100
+6% +$2.35M 0.18% 108
2025
Q1 		$42.5M Buy
87,741
+800
+0.9% +$373K 0.21% 95
2024
Q4 		$35M Buy
+86,941
New +$40.3M 0.17% 113

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

KLP Kapitalforvaltning's VRTX Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Vertex Pharmaceuticals (VRTX) stake by 2.7% in Q1 2026, buying an estimated $1.16M and bringing the position to 95,381 shares worth $42.6M. The position accounts for 0.17% of the portfolio, ranked #111.

KLP Kapitalforvaltning first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • KLP Kapitalforvaltning held 95,381 shares of Vertex Pharmaceuticals worth $42.6M as of Q1 2026.
  • KLP Kapitalforvaltning bought 2,480 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.16M.
  • Vertex Pharmaceuticals made up 0.17% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #111 holding.
  • KLP Kapitalforvaltning first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.